Acamprosate and Methazolamide for Essential Tremor

Summary

This is an investigator initiated study is designed to evaluate the anti-tremor benefits of two marketed medications, methazolamide and acamprosate in subjects with a diagnosis of essential tremor (ET).

Timeline

Start

2016-03

Primary completion

2017-06

Completion

2017-12

Drugs

Indications